Murali Aravamudan is a serial entrepreneur, inventor, engineer and Founder and CEO of Nference, an AI-based software platform that synthesizes siloed biomedical knowledge for insights and makes it computable. He has built, led and exited several successful media and telecom technology companies prior to founding Nference in 2015. Currently, he is also the CEO of Qrativ, a drug development joint venture between Nference and Mayo Clinic.